{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:38:14Z","timestamp":1790710694047,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000848","name":"University of Edinburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001069","name":"Women and Infants Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006070","name":"Universidad de los Andes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020265","name":"Stan Perron Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030652","name":"Department of Obstetrics and Gynecology, Baylor College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030652","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ajog.2023.09.013","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T11:58:02Z","timestamp":1695124682000},"page":"330-339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Antenatal corticosteroids: an updated assessment of anticipated benefits and potential risks"],"prefix":"10.1016","volume":"230","author":[{"given":"Alan H.","family":"Jobe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew W.","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2023.09.013_bib1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ajog.2018.04.007","article-title":"Antenatal corticosteroids: an assessment of anticipated benefits and potential risks","volume":"219","author":"Jobe","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.09.013_bib2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1542\/peds.50.4.515","article-title":"A\u00a0controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants","volume":"50","author":"Liggins","year":"1972","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2023.09.013_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1471-0528.1990.tb01711.x","article-title":"The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials","volume":"97","author":"Crowley","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2023.09.013_bib4","first-page":"1","article-title":"Effect of corticosteroids for fetal maturation on perinatal outcomes","volume":"12","year":"1994","journal-title":"NIH Consens Statement"},{"key":"10.1016\/j.ajog.2023.09.013_bib5","first-page":"CD004454","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth","volume":"12","author":"McGoldrick","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2023.09.013_bib6","first-page":"CD003935","article-title":"Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes","volume":"4","author":"Walters","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2023.09.013_bib7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41390-020-01249-w","article-title":"Antenatal corticosteroids: a reappraisal of the drug formulation and dose","volume":"89","author":"Jobe","year":"2021","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ajog.2023.09.013_bib8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.siny.2019.05.003","article-title":"Optimizing antenatal corticosteroid therapy","volume":"24","author":"Kemp","year":"2019","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2023.09.013_bib9","doi-asserted-by":"crossref","first-page":"F195","DOI":"10.1136\/archdischild-2012-303157","article-title":"Behavioural, educational and respiratory outcomes of antenatal betamethasone for term caesarean section (ASTECS trial)","volume":"98","author":"Stutchfield","year":"2013","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.ajog.2023.09.013_bib10","first-page":"e1707","article-title":"The C\u2217STEROID Trial. Antenatal corticosteroids prior to planned caesarean section delivery from 35+0 to 39+6 weeks gestation; a randomised controlled trial assessing the effects on neonatal respiratory morbidity and glycaemic control","volume":"10","author":"Groom","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ajog.2023.09.013_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.siny.2022.101334","article-title":"Perinatal care for the extremely preterm infant","volume":"27","author":"Usuda","year":"2022","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2023.09.013_bib12","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1056\/NEJMoa1516783","article-title":"Antenatal betamethasone for women at risk for late preterm delivery","volume":"374","author":"Gyamfi-Bannerman","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2023.09.013_bib13","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/bmj.38547.416493.06","article-title":"Antenatal Steroids for Term Elective Caesarean Section (ASTECS) Research Team. Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomised trial","volume":"331","author":"Stutchfield","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2023.09.013_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282477","article-title":"Consortium for the Study of Pregnancy Treatments (Co-OPT): an international birth cohort to study the effects of antenatal corticosteroids","volume":"18","author":"Frier","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2023.09.013_bib15","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00404-022-06724-9","article-title":"Timing of antenatal steroid administration for imminent preterm birth: results of a prospective observational study in Germany","volume":"308","author":"Humbeck","year":"2023","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2023.09.013_bib16","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jamapediatrics.2022.3251","article-title":"Antenatal steroid exposure among term newborns","volume":"176","author":"Freret","year":"2022","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.ajog.2023.09.013_bib17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jpeds.2022.09.050","article-title":"Antenatal corticosteroid exposure is associated with childhood mental disorders in late preterm and term infants","volume":"253","author":"Lin","year":"2023","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ajog.2023.09.013_bib18","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2020.3937","article-title":"Associations between maternal antenatal corticosteroid treatment and mental and behavioral disorders in children","volume":"323","author":"R\u00e4ikk\u00f6nen","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2023.09.013_bib19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1017\/S0033291718004129","article-title":"Associations of antenatal glucocorticoid exposure with mental health in children","volume":"50","author":"Wolford","year":"2020","journal-title":"Psychol Med"},{"key":"10.1016\/j.ajog.2023.09.013_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-062309","article-title":"Corticosteroids to safely reduce neonatal respiratory morbidity after late preterm and term planned caesarean section birth? A randomised placebo-controlled feasibility study","volume":"12","author":"Chan","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajog.2023.09.013_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2018.04.003","article-title":"The global epidemiology of preterm birth","volume":"52","author":"Vogel","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2023.09.013_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2017-000398","article-title":"Antenatal corticosteroids for women at risk of imminent preterm birth in low-resource countries: the case for equipoise and the need for efficacy trials","volume":"2","author":"Vogel","year":"2017","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.ajog.2023.09.013_bib23","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.12702","article-title":"US incidence of late-preterm steroid use and associated neonatal respiratory morbidity after publication of the antenatal late preterm steroids trial, 2015-2017","volume":"5","author":"Clapp","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajog.2023.09.013_bib24","doi-asserted-by":"crossref","first-page":"e1707","DOI":"10.1016\/S2214-109X(22)00434-X","article-title":"Updated WHO recommendations on antenatal corticosteroids and tocolytic therapy for improving preterm birth outcomes","volume":"10","author":"Vogel","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ajog.2023.09.013_bib25","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1111\/1471-0528.17027","article-title":"Royal College of Obstetricians and Gynaecologists. Antenatal corticosteroids to reduce neonatal morbidity and mortality: Green-top Guideline No. 74","volume":"129","author":"Stock","year":"2022","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2023.09.013_bib26","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1097\/AOG.0000000000002237","article-title":"Committee Opinion No. 713: antenatal corticosteroid therapy for fetal maturation","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.09.013_bib27","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1097\/AOG.0000000000004447","article-title":"Medically indicated late-preterm and early-term deliveries: ACOG committee opinion, number 831","volume":"138","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.09.013_bib28","series-title":"Use of antenatal corticosteroids at 22 weeks of gestation","year":"2021"},{"key":"10.1016\/j.ajog.2023.09.013_bib29","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S2352-4642(19)30292-5","article-title":"Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial","volume":"3","author":"Crowther","year":"2019","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.ajog.2023.09.013_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263927","article-title":"Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: a secondary analysis of the ASTEROID Trial","volume":"17","author":"Hofer","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2023.09.013_bib31","first-page":"CD006764","article-title":"Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth","volume":"8","author":"Williams","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2023.09.013_bib32","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(22)01535-5","article-title":"Neonatal outcomes for women at risk of preterm delivery given half dose versus full dose of antenatal betamethasone: a randomised, multicentre, double-blind, placebo-controlled, non-inferiority trial","volume":"400","author":"Schmitz","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2023.09.013_bib33","doi-asserted-by":"crossref","first-page":"L853","DOI":"10.1152\/ajplung.00058.2022","article-title":"One percent of the clinical dose used for antenatal steroid therapy is sufficient to induce lung maturation when administered directly to the preterm ovine fetus","volume":"322","author":"Fee","year":"2022","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.ajog.2023.09.013_bib34","article-title":"Antenatal corticosteroids in Singapore: a clinical and scientific assessment","author":"Gosavi","year":"2022","journal-title":"Singapore Med J"},{"key":"10.1016\/j.ajog.2023.09.013_bib35","doi-asserted-by":"crossref","first-page":"564.e1","DOI":"10.1016\/j.ajog.2021.10.001","article-title":"Betamethasone phosphate reduces the efficacy of antenatal steroid therapy and is associated with lower birthweights when administered to pregnant sheep in combination with betamethasone acetate","volume":"226","author":"Takahashi","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.09.013_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2022.07.030","article-title":"The complex challenge of antenatal steroid therapy nonresponsiveness","author":"Takahashi","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.09.013_bib37","doi-asserted-by":"crossref","first-page":"903.e1","DOI":"10.1016\/j.ajog.2022.06.058","article-title":"Low-dose antenatal betamethasone treatment achieves preterm lung maturation equivalent to that of the World Health Organization dexamethasone regimen but with reduced endocrine disruption in a sheep model of pregnancy","volume":"227","author":"Usuda","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.09.013_bib38","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0002-9378(80)90855-8","article-title":"Results of a double-blind controlled study on the use of betamethasone in the prevention of respiratory distress syndrome","volume":"136","author":"Doran","year":"1980","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.09.013_bib39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jpeds.2022.10.028","article-title":"Betamethasone for preterm birth: Auckland Steroid Trial full results and new insights 50 years on","volume":"255","author":"Walters","year":"2023","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ajog.2023.09.013_bib40","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1080\/14767058.2020.1819977","article-title":"Antenatal corticosteroids and the influence of sex on morbidity and mortality of preterm infants","volume":"35","author":"Ramos-Navarro","year":"2022","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2023.09.013_bib41","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1056\/NEJMoa2022398","article-title":"Antenatal dexamethasone for early preterm birth in low-resource countries","volume":"383","author":"Oladapo","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2023.09.013_bib42","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(14)61651-2","article-title":"A\u00a0population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial","volume":"385","author":"Althabe","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2023.09.013_bib43","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(15)60953-9","article-title":"Antenatal corticosteroids for preterm births in resource-limited settings","volume":"385","author":"Visser","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2023.09.013_bib44","article-title":"Antenatal dexamethasone for late preterm birth: a multi-centre, two-arm, parallel, double-blind, placebo-controlled, randomized trial","volume":"44","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ajog.2023.09.013_bib45","series-title":"ACTION III: a multi-country, multi-centre, three-arm, parallel group","year":"2021"},{"key":"10.1016\/j.ajog.2023.09.013_bib46","first-page":"CD004454","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth","volume":"3","author":"Roberts","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2023.09.013_bib47","doi-asserted-by":"crossref","first-page":"80.e1","DOI":"10.1016\/j.ajog.2022.07.026","article-title":"Long-term childhood outcomes for babies born at term who were exposed to antenatal corticosteroids","volume":"228","author":"Osteen","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.09.013_bib48","doi-asserted-by":"crossref","DOI":"10.1111\/1471-0528.17230","article-title":"Potential missed opportunities for antenatal corticosteroid exposure and outcomes among periviable births: observational cohort study","author":"Travers","year":"2022","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2023.09.013_bib49","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2022.0483","article-title":"Evaluation of long-term outcomes associated with preterm exposure to antenatal corticosteroids: a systematic review and meta-analysis","volume":"176","author":"Ninan","year":"2022","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.ajog.2023.09.013_bib50","doi-asserted-by":"crossref","first-page":"R825","DOI":"10.1152\/ajpregu.00193.2017","article-title":"Efficacy and safety of antenatal steroids","volume":"315","author":"Kemp","year":"2018","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.ajog.2023.09.013_bib51","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/cts.12724","article-title":"Pharmacokinetics and pharmacodynamics of intramuscular and oral betamethasone and dexamethasone in reproductive age women in India","volume":"13","author":"Jobe","year":"2020","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.ajog.2023.09.013_bib52","doi-asserted-by":"crossref","first-page":"775.e1","DOI":"10.1016\/j.ajog.2016.08.017","article-title":"Maternofetal pharmacokinetics and fetal lung responses in chronically catheterized sheep receiving constant, low-dose infusions of betamethasone phosphate","volume":"215","author":"Kemp","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.09.013_bib53","doi-asserted-by":"crossref","first-page":"301.e1","DOI":"10.1016\/j.ajog.2018.05.007","article-title":"The efficacy of antenatal steroid therapy is dependent on the duration of low-concentration fetal exposure: evidence from a sheep model of pregnancy","volume":"219","author":"Kemp","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.09.013_bib54","doi-asserted-by":"crossref","first-page":"9039","DOI":"10.1038\/s41598-019-45171-6","article-title":"Dosing and formulation of antenatal corticosteroids for fetal lung maturation and gene expression in rhesus macaques","volume":"9","author":"Schmidt","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajog.2023.09.013_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222817","article-title":"Oral dosing for antenatal corticosteroids in the rhesus macaque","volume":"14","author":"Schmidt","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2023.09.013_bib56","doi-asserted-by":"crossref","first-page":"183.e1","DOI":"10.1016\/j.ajog.2019.08.046","article-title":"The duration of fetal antenatal steroid exposure determines the durability of preterm ovine lung maturation","volume":"222","author":"Kemp","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.09.013_bib57","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/jamapediatrics.2017.0602","article-title":"Association of short antenatal corticosteroid administration-to-birth intervals with survival and morbidity among very preterm infants: results from the EPICE cohort","volume":"171","author":"Norman","year":"2017","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.ajog.2023.09.013_bib58","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.tips.2018.11.002","article-title":"Non-genomic effects of glucocorticoids: an updated view","volume":"40","author":"Panettieri","year":"2019","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.ajog.2023.09.013_bib59","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nrendo.2014.74","article-title":"Glucocorticoids and fetal programming part 2: mechanisms","volume":"10","author":"Moisiadis","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ajog.2023.09.013_bib60","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ygcen.2017.07.016","article-title":"Glucocorticoid programming of neuroimmune function","volume":"256","author":"Walker","year":"2018","journal-title":"Gen Comp Endocrinol"},{"key":"10.1016\/j.ajog.2023.09.013_bib61","doi-asserted-by":"crossref","first-page":"L784","DOI":"10.1152\/ajplung.00018.2022","article-title":"Continuous but not pulsed low-dose fetal betamethasone exposures extend the durability of antenatal steroid therapy","volume":"322","author":"Takahashi","year":"2022","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.ajog.2023.09.013_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101916","article-title":"Effect of antenatal corticosteroid administration-to-birth interval on maternal and newborn outcomes: a systematic review","volume":"58","author":"McDougall","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ajog.2023.09.013_bib63","article-title":"Effect of dexamethasone on newborn survival at different administration-to-birth intervals: a secondary analysis of the WHO ACTION (Antenatal CorticosTeroids for Improving Outcomes in Preterm Newborn)-I trial","volume":"53","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ajog.2023.09.013_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2019.100077","article-title":"Optimal timing of antenatal corticosteroid administration and preterm neonatal and early childhood outcomes","volume":"2","author":"Battarbee","year":"2020","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.ajog.2023.09.013_bib65","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jamapediatrics.2015.1631","article-title":"Association between transient newborn hypoglycemia and fourth-grade achievement test proficiency: a population-based study","volume":"169","author":"Kaiser","year":"2015","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.ajog.2023.09.013_bib66","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/jamapediatrics.2017.1579","article-title":"Association of neonatal glycemia with neurodevelopmental outcomes at 4.5 years","volume":"171","author":"McKinlay","year":"2017","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.ajog.2023.09.013_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2022.100687","article-title":"Latency of late preterm steroid administration to delivery and risk of neonatal hypoglycemia","volume":"4","author":"McElwee","year":"2022","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.ajog.2023.09.013_bib68","doi-asserted-by":"crossref","first-page":"921.e1","DOI":"10.1016\/j.ajog.2020.05.032","article-title":"Variability in the efficacy of a standardized antenatal steroid treatment was independent of maternal or fetal plasma drug levels: evidence from a sheep model of pregnancy","volume":"223","author":"Takahashi","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.09.013_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002746","article-title":"Antenatal corticosteroid therapy (ACT) and size at birth: a population-based analysis using the Finnish Medical Birth Register","volume":"16","author":"Rodriguez","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajog.2023.09.013_bib70","doi-asserted-by":"crossref","first-page":"759.e1","DOI":"10.1016\/j.ajog.2022.05.060","article-title":"Associations between antenatal corticosteroid exposure and neurodevelopment in infants","volume":"227","author":"Tao","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.09.013_bib71","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-075835","article-title":"Association between antenatal corticosteroids and risk of serious infection in children: nationwide cohort study","volume":"382","author":"Yao","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2023.09.013_bib72","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/ppe.12886","article-title":"Little evidence for long-term harm from antenatal corticosteroids in a population-based very low birthweight young adult cohort","volume":"36","author":"Darlow","year":"2022","journal-title":"Paediatr Perinat Epidemiol"},{"key":"10.1016\/j.ajog.2023.09.013_bib73","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/S0140-6736(05)66617-2","article-title":"Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial","volume":"365","author":"Dalziel","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2023.09.013_bib74","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1017\/S2040174414000579","article-title":"Antenatal glucocorticoids: where are we after forty years?","volume":"6","author":"McKinlay","year":"2015","journal-title":"J\u00a0Dev Orig Health Dis"},{"key":"10.1016\/j.ajog.2023.09.013_bib75","series-title":"Long-term effects of breastfeeding: a systematic review","author":"Bernardo","year":"2013"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823006191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823006191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:38:08Z","timestamp":1762079888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937823006191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0002937823006191"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2023.09.013","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antenatal corticosteroids: an updated assessment of anticipated benefits and potential risks","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2023.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}